[go: up one dir, main page]

MX2017002385A - Metodos y reactivos para la prevencion y/o el tratamiento de infecciones. - Google Patents

Metodos y reactivos para la prevencion y/o el tratamiento de infecciones.

Info

Publication number
MX2017002385A
MX2017002385A MX2017002385A MX2017002385A MX2017002385A MX 2017002385 A MX2017002385 A MX 2017002385A MX 2017002385 A MX2017002385 A MX 2017002385A MX 2017002385 A MX2017002385 A MX 2017002385A MX 2017002385 A MX2017002385 A MX 2017002385A
Authority
MX
Mexico
Prior art keywords
prevention
treatment
infection
reagents
methods
Prior art date
Application number
MX2017002385A
Other languages
English (en)
Other versions
MX378754B (es
Inventor
MAÑEZ MENDILUCE Rafael
COSTA VALLÉS Cristina
PÉREZ CRUZ Magdiel
BELLO GIL Daniel
Original Assignee
Inst D'investigació Biomèdica De Bellvitge (Idibell)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst D'investigació Biomèdica De Bellvitge (Idibell) filed Critical Inst D'investigació Biomèdica De Bellvitge (Idibell)
Publication of MX2017002385A publication Critical patent/MX2017002385A/es
Publication of MX378754B publication Critical patent/MX378754B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere al campo de agentes terapéuticos y, más en particular, a agentes y composiciones para la prevención y/o el tratamiento de infección causada por bacterias del tracto gastrointestinal en un sujeto, basándose dichos agentes y composiciones en agentes que comprenden un resto de a-galactosilo terminal.
MX2017002385A 2014-08-22 2015-08-24 Métodos y reactivos para la prevención y/o el tratamiento de infecciones. MX378754B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382324.3A EP2987503A1 (en) 2014-08-22 2014-08-22 Methods and reagents for prevention and/or treatment of infection
PCT/EP2015/069334 WO2016026981A1 (en) 2014-08-22 2015-08-24 Methods and reagents for prevention and/or treatment of infection

Publications (2)

Publication Number Publication Date
MX2017002385A true MX2017002385A (es) 2017-06-30
MX378754B MX378754B (es) 2025-03-10

Family

ID=51485539

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002385A MX378754B (es) 2014-08-22 2015-08-24 Métodos y reactivos para la prevención y/o el tratamiento de infecciones.

Country Status (12)

Country Link
EP (2) EP2987503A1 (es)
JP (1) JP6612346B2 (es)
KR (1) KR102492850B1 (es)
CN (1) CN107073020B (es)
AU (1) AU2015305108B2 (es)
CA (1) CA2958600C (es)
ES (1) ES2759565T3 (es)
MX (1) MX378754B (es)
PL (1) PL3183003T3 (es)
RU (1) RU2698099C2 (es)
SG (1) SG11201806985WA (es)
WO (1) WO2016026981A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7383297B2 (ja) * 2017-11-10 2023-11-20 ザ・ジョンズ・ホプキンス・ユニバーシティー デンドリマー送達システムおよびそれを使用する方法
CN108646029B (zh) * 2018-05-14 2021-07-02 中国食品药品检定研究院 人抗-Gal-IgG抗体检测试剂盒及其制备方法和用途
WO2020027158A1 (ja) * 2018-07-31 2020-02-06 住友金属鉱山株式会社 リチウムイオン二次電池用正極活物質、リチウムイオン二次電池用正極活物質の製造方法、リチウムイオン二次電池
CA3192148A1 (en) * 2020-09-08 2022-03-17 The Johns Hopkins University Galactosylated dendrimers for targeted intracellular delivery to hepatocytes
EP3964235A1 (en) * 2020-09-08 2022-03-09 RemAb Therapeutics SL Glycoconjugates and medical uses thereof
CN116515102B (zh) * 2022-01-21 2025-04-18 苏州万维生命科学技术有限公司 星型β-抗菌糖肽、其制备方法及应用
WO2023138211A1 (zh) * 2022-01-21 2023-07-27 苏州万维生命科学技术有限公司 星型β-抗菌糖肽、其制备方法及应用
US20240123420A1 (en) * 2022-10-12 2024-04-18 Kelly Nicholson Furnace for endothermic processes
CN117269517B (zh) * 2022-10-18 2024-04-16 天津德祥生物技术股份有限公司 一种血型抗原三糖b类似物蛋白偶联物在血型抗体检测中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK131083A (da) * 1982-03-23 1983-09-24 Svenska Sockerfabriks Ab Fremgangsmaade til fremstilling af terapeutiske eller diagnostiske praeparater
US5262165A (en) 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
PT836506E (pt) 1995-06-07 2003-04-30 Ortho Mcneil Pharm Inc Penso transdermico para administracao de 17-desacetil norgestimato so ou em combinacao com um estrogenio
EP0970114B1 (en) 1997-04-18 2006-07-12 Novartis AG Neoglycoproteins
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
WO1999052561A1 (en) * 1998-04-15 1999-10-21 Baxter International Inc. Inhibition of xenoreactive antibodies
CN1395579A (zh) * 2000-01-13 2003-02-05 阿尔开密亚有限公司 含α－D－GAL(1→3)GAL的寡糖的合成方法
US7318926B2 (en) * 2003-02-06 2008-01-15 Tripep Ab Glycosylated specificity exchangers
AU2003901008A0 (en) 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections
US7915235B2 (en) * 2006-03-20 2011-03-29 Brian Dieckgraefe High affinity ligands bind to clostridium difficile toxin A
US8361441B2 (en) 2008-03-11 2013-01-29 Taipei Medical University Detection and therapy of bacterial infection caused by Enterobacteriaceae
US7928077B2 (en) * 2008-07-11 2011-04-19 Academia Sinica Alpha-galactosyl ceramide analogs and their use as immunotherapies

Also Published As

Publication number Publication date
MX378754B (es) 2025-03-10
PL3183003T3 (pl) 2020-03-31
SG11201806985WA (en) 2018-09-27
RU2698099C2 (ru) 2019-08-22
AU2015305108A1 (en) 2017-04-06
EP3183003B1 (en) 2019-07-31
RU2017108569A3 (es) 2019-03-13
EP3183003A1 (en) 2017-06-28
CA2958600C (en) 2023-01-10
KR20170043556A (ko) 2017-04-21
RU2017108569A (ru) 2018-09-24
JP2017525763A (ja) 2017-09-07
CN107073020B (zh) 2019-12-10
CA2958600A1 (en) 2016-02-25
WO2016026981A1 (en) 2016-02-25
ES2759565T3 (es) 2020-05-11
JP6612346B2 (ja) 2019-11-27
AU2015305108B2 (en) 2021-03-18
CN107073020A (zh) 2017-08-18
EP2987503A1 (en) 2016-02-24
KR102492850B1 (ko) 2023-01-26

Similar Documents

Publication Publication Date Title
MX2017002385A (es) Metodos y reactivos para la prevencion y/o el tratamiento de infecciones.
CY1123127T1 (el) Χρηση μιας συνθεσης που περιλαμβανει μικροοργανισμους για να αυξηθει η εντερικη παραγωγη βουτυρικου οξεος, φολικου οξεος η νιασινης η/και για να μειωθει η εντερικη παραγωγη σουκινικου οξεος
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
CO2017013443A2 (es) Composiciones que comprenden cepas bacterianas del género blautia
ME03424B (me) Kompozicije koje sadrže bakterijski soj blautia hydrogenotrophica za upotrebu u liječenju bakterisjkih infekcija gastrointestinalnog trakta
MX381417B (es) Inhibidores de glucosidasa.
MX386935B (es) Profármacos de fumaratos y su uso en el tratamiento de diferentes enfermedades.
MX2016009898A (es) Tratamientos para acne resistente.
PH12017500207A1 (en) Indoles for use in influenza virus infection
MX2017006302A (es) Derivados de adenina que son utiles en el tratamiento de enfermedades alergicas u otras afecciones inflamatorias.
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
EA201790273A1 (ru) Флагеллиновые композиции и их применение
WO2016142445A3 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
EA201691766A1 (ru) Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций
EA201591761A1 (ru) Композиции на основе наночастиц
MX364942B (es) Peptidos antimicrobianos.
CO2017001658A2 (es) Compuestos tricíclicos que contienen nitrógeno para el tratamiento de la infección por neisseria gonorrhoeae
EA201790312A1 (ru) Комбинации лекарственных средств для лечения множественной миеломы
CL2017001025A1 (es) Compuestos para usarse en el tratamiento antihelmíntico
BR112017007194A2 (pt) compostos de hidroxil purina e aplicações dos mesmos
CL2017000178A1 (es) Compuestos para usar en el tratamiento antihelmíntico
MX2017009094A (es) Derivado de polimixina y usos del mismo.
BR112015016033A2 (pt) composições e métodos para tratamento de infecções por bactérias
EA201690227A1 (ru) Азаиндольные соединения, их получение и способы их применения
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.